Algernon Pharmaceuticals Announces Short Form Prospectus Unit Offering
July 04, 2019 07:00 ET
|
Algernon Pharmaceuticals
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British...
Algernon Pharmaceuticals Begins Trading on The CSE Under The Symbol AGN
February 19, 2019 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce...
Breathtec Announces Name Change to Algernon Pharmaceuticals
February 14, 2019 07:00 ET
|
Breathtec Biomedical Inc.
New corporate identity aligned with the Company's main strategy to be a global leader in the treatment of liver disease (NASH), chronic kidney disease and inflammatory bowel disease. The company's...